Stock Scorer

SOPHiA GENETICS SA (SOPH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 7M 14M 21M Q2 '22: 11.7M Q2 '23: 15.1M Q2 '24: 15.8M Q2 '25: 18.3M Q2 '22 Q2 '23 Q2 '24 Q2 '25

Gross Profit Quarterly

0 5M 10M 15M Q2 '22: 7.6M Q2 '23: 10M Q2 '24: 10.8M Q2 '25: 12.3M Q2 '22 Q2 '23 Q2 '24 Q2 '25

Operating Income Quarterly

-27M -18M -9M 0 9M 18M 27M Q2 '22: -24.1M Q2 '23: -20M Q2 '24: -15M Q2 '25: -18.5M Q2 '22 Q2 '23 Q2 '24 Q2 '25

Net Income Quarterly

-27M -18M -9M 0 9M 18M 27M Q2 '22: -24.7M Q2 '23: -21.4M Q2 '24: -15.2M Q2 '25: -22.4M Q2 '22 Q2 '23 Q2 '24 Q2 '25

Cost of Revenue Quarterly

0 2.5M 5M 7.5M Q2 '22: 4M Q2 '23: 5M Q2 '24: 5M Q2 '25: 6.1M Q2 '22 Q2 '23 Q2 '24 Q2 '25

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '22: 64.1M Q2 '23: 64.5M Q2 '24: 65.9M Q2 '25: 67.3M Q2 '22 Q2 '23 Q2 '24 Q2 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS Annual

-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 FY21: -1.33 FY22: -1.36 FY23: -1.22 FY24: -0.95 FY25: -1.17 FY21 FY22 FY23 FY24 FY25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for SOPH: Operating Cash Flow, Free Cash Flow. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.